About Naranhay Ltd.
Naranhay Ltd was established in Israel in 2020 by a team of visionaries including Dr. Aharon Mezin, Maxim Mikhailov, Dr. Yehoshua Maor, and Semyon Saharov. Our mission is deeply rooted in the field of life sciences, with a primary focus on researching and developing Cannabis-based biotechnology solutions exclusively for medical and preventive purposes. We are committed to addressing unmet needs in this dynamic field, leveraging cutting-edge technologies and scientific expertise.
Collaborating with leading laboratories specializing in biotechnology, we are at the forefront of combating microorganisms resistant to antibiotics. Through extensive in vitro experiments, we are pioneering breakthroughs in the treatment of antibiotic-resistant pathogens, contributing to the advancement of medical science.
Led by Dr. Yehoshua Maor and supported by our dedicated team, Naranhay operates within the esteemed laboratory of Phytor Lab for Drug Development at the Jerusalem Biotechnology Park, situated within the Hadassah Ein Kerem campus. Here, we harness innovative technologies and a profound understanding of cannabinoid pharmacology to develop medical and preventive treatments. Our focus lies primarily in combating antibiotic resistance, particularly in areas such as neurodegenerative diseases like Alzheimer’s, where microbial involvement is evident, and in the prevention of cancer metastasis and diabetes mellitus, where microbial roles have been identified.
At Naranhay Ltd, we are currently in the developmental phase of our antibiotic
resistance technology, with plans to expand our efforts into cancer metastasis and diabetes treatment within the next 3-5 years. With a steadfast commitment to innovation and scientific excellence, we strive to revolutionize healthcare and improve lives worldwide.
Our Team
Dr. Aaron Mazin
Founder/CEO
Dr. Aaron Mazin is an esteemed General Medicine practitioner, boasting an extensive 27-year career that has encompassed roles in both hospital and polyclinic settings.
With a wealth of experience under his belt, Dr. Mazin has cultivated a deep understanding of various medical specialties, honing his skills in diagnostics, treatment modalities, and patient care.
His journey in the field has been marked by a steadfast commitment to excellence, evidenced by his dedication to staying abreast of the latest medical advancements and techniques.
Unparalleled expertise and unwavering dedication make him a highly sought-after professional in the medical community, poised to make enduring contributions to healthcare innovation and patient wellness for years to come.
Dr. Yehoshua Maor, PhD. Founder/CSO
Dr. Yehoshua Maor is a Pharmacologist/Toxicologist at Phytor Lab for Drug Development in Jerusalem, Israel.
With a diverse range of expertise spanning multidisciplinary and trans-disciplinary areas, Dr.
Maor brings extensive knowledge in medicinal, organic, and analytical chemistry, as well as specialized skills in cannabinoids, pharmacology, toxicology, and environmental health.
He has demonstrated proficiency in conducting research, analyzing data, and developing innovative solutions in the field of drug development.
Dr. Maor’s dedication to advancing scientific understanding and improving public health outcomes makes him a valuable asset to any pharmaceutical research team.
Simeon Saharov, Adv.
Founder/COO
Mr. Simeon Saharov is a seasoned lawyer with a career spanning over two decades since 1997.
He has held prestigious roles as a director and manager in various international companies, operating extensively across Europe, Israel, the Far East, and China.
With his comprehensive understanding of legal frameworks and business operations, Mr. Saharov has been instrumental in driving success and growth in diverse industries.
Additionally, he has leveraged his expertise as a consultant in the establishment and management of mines, particularly in the diamond industry in Africa.
His strategic insights, coupled with his ability to navigate complex legal and business landscapes, make him a valuable asset in both legal and corporate spheres.
Mr. Saharov’s commitment to excellence and his proven track record of delivering results underscore his reputation as a highly respected professional in his field.
Maxim Mikhaylov
Founder/CFO
Mr. Maxim Mikhaylov brings to the table a wealth of experience garnered over many years in the realm of business development, spanning diverse sectors including production, trade, and finance.
His proven track record speaks volumes of his adeptness in attracting investment for cutting-edge technologies, coupled with his keen eye for identifying and capitalizing on emerging business prospects.
Beyond mere transactional engagement, Mr. Mikhaylov is deeply committed to fostering long-term partnerships and cultivating new avenues of growth and profitability.
Leveraging his comprehensive understanding of market dynamics and emerging trends, he consistently identifies untapped potential and develops tailored strategies to capitalize on evolving market landscapes.
His dedication to excellence and relentless pursuit of innovation have earned him a reputation as a visionary leader capable of navigating complex business environments with confidence and agility, poised to make enduring contributions to the realm of business development.